Fusion proteins comprising carriers that can induce a dual immune response
First Claim
1. A fusion protein for producing a dual immune response in a vertebrate, which fusion protein comprises:
- (a) a first proteinaceous portion analogous to all or part of a peptide endogenously synthesized within the vertebrate, the activity of which peptide is to be inhibited within the vertebrate, and which proteinaceous portion by itself is incapable of eliciting an effective immunoinhibitory response in said vertebrate;
connected to (b) a second proteinaceous portion analogous to all or part of an immunogen from a pathogen, which pathogen is capable of pathogenically infecting the vertebrate;
the portion (b) causing the vertebrate'"'"'s immune system to recognize the portion (a) and produce a response that;
(i) inhibits the activity of the peptide endogenously synthesized within the vertebrate; and
(ii) protects the vertebrate from infection by the pathogen, when the vertebrate is vaccinated with an effective amount of the fusion protein.
0 Assignments
0 Petitions
Accused Products
Abstract
The subject invention provides a fusion protein for producing a dual immune response in a vertebrate, which fusion protein comprises: (a) a first proteinaceous portion analogous to all or part of a peptide endogenously synthesized within the vertebrate, the activity of which peptide is to be inhibited within the vertebrate, and which proteinaceous portion by itself is incapable of eliciting an effective immunoinhibitory response in said vertebrate; connected to (b) a second proteinaceous portion analogous to all or part of an immunogen from a pathogen, which pathogen is capable of pathogenically infecting the vertebrate; the portion (b) causing the vertebrate'"'"'s immune system to recognize the portion (a) and produce a response that: (i) inhibits the activity of the peptide endogenously synthesized within the vertebrate; and (ii) protects the vertebrate from infection by the pathogen, when the vertebrate is vaccinated with an effective amount of the fusion protein. The subject invention also provides fusion proteins which comprise a proteinaceous portion (b) that is a carrier that is analogous to all or part of a BHV-1 antigen, which fusion proteins induce in a vertebrate vaccinated with an effective amount of such fusion protein an immune response that inhibits the activity of a peptide as recited in (a), above.
34 Citations
17 Claims
-
1. A fusion protein for producing a dual immune response in a vertebrate, which fusion protein comprises:
-
(a) a first proteinaceous portion analogous to all or part of a peptide endogenously synthesized within the vertebrate, the activity of which peptide is to be inhibited within the vertebrate, and which proteinaceous portion by itself is incapable of eliciting an effective immunoinhibitory response in said vertebrate;
connected to(b) a second proteinaceous portion analogous to all or part of an immunogen from a pathogen, which pathogen is capable of pathogenically infecting the vertebrate;
the portion (b) causing the vertebrate'"'"'s immune system to recognize the portion (a) and produce a response that;
(i) inhibits the activity of the peptide endogenously synthesized within the vertebrate; and
(ii) protects the vertebrate from infection by the pathogen, when the vertebrate is vaccinated with an effective amount of the fusion protein. - View Dependent Claims (2, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)
-
-
3. A fusion protein for producing an immune response in a vertebrate, which fusion protein comprises:
-
(a) a first proteinaceous portion analogous to all or part of a peptide the activity of which is to be inhibited within the vertebrate, and which proteinaceous portion by itself is incapable of eliciting an effective immunoinhibitory response in said vertebrate;
connected to(b) a second proteinaceous portion analogous to all or part of a BHV-1 antigen;
the second proteinaceous portion (b) causing the vertebrate'"'"'s immune system to recognize the first proteinaceous portion (a) and produce an immune response capable of inhibiting the activity of the peptide within the vertebrate when the vertebrate is vaccinated with an effective amount of the fusion protein. - View Dependent Claims (4, 5)
-
Specification